Research Article
BibTex RIS Cite

Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?

Year 2021, , 380 - 387, 21.12.2021
https://doi.org/10.47493/abantmedj.986721

Abstract

Amaç: Pulmoner emboli (PE) tüm dünyada yaygın olarak görülen ,tanısında güçlükler yaşanan önemli bir morbidite ve mortalite nedenidir. Son zamanlarda yapılan çalışmalarda pulmoner emboli tanısı ve prognozunu öngörmede ortalama trombosit hacminin(OTH) bir belirteç olarak kullanılabileceği gösterilmiştir. OTH nin , mortalite açısından bağımsız bir belirteç olabileceği ile ilgili çalışmalar da mevcuttur. Çalışmamızda OTH’nin genel ve30 günlük mortalite üzerine etkisini ve OTH ile pulmoner emboli şiddet indeksi (PESİ) skorlama sistemi arasındaki korelasyonu değerlendirmeyi amaçladık.
Gereç ve yöntem: Hastanemize Ocak.2018-Aralık.2019 tarihleri arasında Akut PE tanısı ile yatan 273 hasta retrospektif olarak incelendi. Hastaların demografik verileri, komorbiditeleri fizik muayene, labaratuvar tetkikleri, ekokardiyografi, venöz doppler USG, pulmoner Bt anjiografi bulguları kayıt altına alındı. PESİ ve basitleştirilmiş pulmoner emboli şiddet indeksi (sPESİ) hesaplandı. Genel ve 30 günlük mortalite hesaplandı. İstatistiksel analizi için SPSS 22.0 programı kullanıldı.
Bulgular: Hastaların %56,8’i erkek, %43,2’si kadın olup yaş ortalaması 57,15±15,50 yıl idi. 273 hastanın 232’si (%84,98) sağ ve 41’i (%15,02) ölmüştü. Cinsiyetle mortalite arasında istatistiksel anlamlı bir ilişki saptanmadı (p=0,80). PESİ düşük riskli hastaların OTH ortalaması 8,31±1,12fL ,PESİ yüksek riskli hastaların OTH ortalaması 8,28±1,03fL olup OTH değerlerinin ortalaması arasında istatistiksel olarak anlamlı bir ilişki saptanmadı (p=0,61). Otuz gün içinde sağ olan hastaların OTH değerlerinin ortalaması 8,29±1,09fL, ölen hastaların OTH değerlerinin ortalaması 8,78±0,92fL idi. Ölen ve sağ hastaların OTH ortalama değerleri arasında istatistiksel olarak anlamlı bir ilişki bulunmadı (p=0,64).
Sonuç: Çalışmamızda OTH değeri ile erken ve genel mortalite arasında bir ilişki saptamadık. PESİ , sPESİ düşük ve yüksek riskli hastaların OTH ortalama değerleri arasında istatistiksel olarak anlamlı bir korelasyon saptamadık (p=0.61, p=95). Fazla sayıda vakayla prospektif çalışmalara ihtiyaç duyulmaktadır.

Supporting Institution

yoktur

Project Number

yoktur

References

  • 1.Pomero F, Fenoglio L, Melchio R, Serraino C, Ageno W, Dentali F. Incidenceanddiagnosis of pulmonaryembolism in NorthernItaly: a population-basedstudy. Europeanjournal of internalmedicine. 2013;24(7):e77-78.
  • 2.Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and nopre-existing cardiacorpulmonary disease. Chest. 1991;100(3):598-603.
  • 3.Kruip MJ, Leclercq MG, HeulCvd, Prins MH, Bller HR. Diagnostic strategies for excluding pulmonary embolism in clinical out come studies: a systematic review. Annals of internal medicine. 2003;138(12):941-951.
  • 4.Konstantinides S, Goldhaber SZ. Pulmonary embolism: risk assessment and management. European heart journal. 2012;33(24):3014-3022.
  • 5.Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model forpulmonary embolism. American journal of respiratory and critical caremedicine. 2005;172(8):1041-1046.
  • 6.Jiménez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism forinitial out patient therapy. Chest. 2007;132(1):24-30. 56. Righini M, Roy P-M, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. Journal of thrombosis and haemostasis: JTH. 2011;9(10):2115-2117.
  • 7. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-9.
  • 8. Righini M, Roy PM, Meyer G, et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011;9:2115-7.
  • 9.Lancé MD, Sloep M, Henskens YM, Marcus MA. Meanplateletvolume as a diagnostic marker for cardio vascular disease: drawbacks of preanalytical conditions and measuring techniques. Clinical and Applied Thrombosis/Hemostasis. 2012;18(6):561-568.
  • 10.Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart. 2010;96(6):460-465.
  • 11.Fei Y, Zong G-q, Chen J, Liu R-m. Evaluation of thevalue of d-dimer, P-selectin, and platelet count for prediction of portal vein thrombosis after devascularization. Clinical and Applied Thrombosis/Hemostasis. 2016;22(5):471-475.
  • 12.Sansanayudh N, Muntham D, Yamwong S, Sritara P, Akrawichien T, Thakkinstian A. The association between mean platelet volume and cardiovascular risk factors. European Journal of Internal Medicine. 2016;30:37-42.
  • 13.Díaz JM, Boietti BR, Vazquez FJ, et al. Mean platelet volume as a prognostic factor for venous thromboembolic disease. Revistamedica de Chile. 2019;147(2):145-152.
  • 14. Chung T, Connor D, Joseph J, et al. Platelet activation in acute pulmonary embolism. Journal of Thrombosis and Haemostasis. 2007;5(5):918-924.
  • 15. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thrombo embolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of internal medicine. 2002;162(10):1182-1189.
  • 16. Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A. Pulmonary embolism in young people. Hämostaseologie. 2014;34(01):88-92.
  • 17. Van Es N, Kraaijpoel N, Klok FA, et al. The original and simplified Wells rules and age‐adjusted D‐dimer testing out pulmonary embolism: an individual patient data meta‐analysis. Journal of Thrombosis and Haemostasis. 2017;15(4):678-684.
  • 18. Hakemi EU, Alyousef T, Dang G, Hakmei J, Doukky R. The prognosticvalue of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015;147(3):685-694.
  • 19. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical out comes in the International Cooperative Pulmonary EmbolismRegistry (ICOPER). The Lancet. 1999;353(9162):1386-1389.
  • 20.Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Mean platelet volum predicts early death in acute pulmonary embolism. Heart. 2010;96(6):460-465.
  • 21. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: TheTask Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). EurHeart J 2008;29:2276e315.
  • 22.Yardan T, Meric M, Kati C, Celenk Y, Atici AG. Mean platelet volume and mean platelet volume/platelet count ratio in risk stratification of pulmonary embolism. Medicina. 2016;52(2):110-115.
  • 23. Şen H, Abakay Ö, Taylan M, Tanrıkulu A, Sezgi C. The importance of mean platelet volume in early mortality of pulmonary embolism. J Clin Exp Invest. 2013;4(3):298- 301.
  • 24. Díaz JM, Boietti BR, Vazquez FJ, et al. Mean platelet volume as a prognostic factor for venous thrombo embolic disease. Revista medica de Chile. 2019;147(2):145-152.
  • 25. Türk Toraks Derneği PulmonerTromboembolizm Tanı ve Tedavi Uzlaşı Raporu 2021. 2021: 22.
  • 26. Ming L, Jiang Z, Ma J, Wang Q, Wu F, Ping J. Platelet-to-lymphocyteratio, neutrophil-to-lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis. Vasa. 2018.
  • 27.Han JS,Park TS,Cho SY,Joh JH,Ahn HJ. Increased mean platelet volume and mean platelet volume/platelet countratio in Korean patients with deep vein thrombosis. Platelets. 2013;24(8):590-593.

Is Mean Platelet Volume a Marker of Early Mortalıty in Acute Pulmonary Embolısm?

Year 2021, , 380 - 387, 21.12.2021
https://doi.org/10.47493/abantmedj.986721

Abstract

Project Number

yoktur

References

  • 1.Pomero F, Fenoglio L, Melchio R, Serraino C, Ageno W, Dentali F. Incidenceanddiagnosis of pulmonaryembolism in NorthernItaly: a population-basedstudy. Europeanjournal of internalmedicine. 2013;24(7):e77-78.
  • 2.Stein PD, Terrin ML, Hales CA, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and nopre-existing cardiacorpulmonary disease. Chest. 1991;100(3):598-603.
  • 3.Kruip MJ, Leclercq MG, HeulCvd, Prins MH, Bller HR. Diagnostic strategies for excluding pulmonary embolism in clinical out come studies: a systematic review. Annals of internal medicine. 2003;138(12):941-951.
  • 4.Konstantinides S, Goldhaber SZ. Pulmonary embolism: risk assessment and management. European heart journal. 2012;33(24):3014-3022.
  • 5.Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model forpulmonary embolism. American journal of respiratory and critical caremedicine. 2005;172(8):1041-1046.
  • 6.Jiménez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism forinitial out patient therapy. Chest. 2007;132(1):24-30. 56. Righini M, Roy P-M, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. Journal of thrombosis and haemostasis: JTH. 2011;9(10):2115-2117.
  • 7. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-9.
  • 8. Righini M, Roy PM, Meyer G, et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011;9:2115-7.
  • 9.Lancé MD, Sloep M, Henskens YM, Marcus MA. Meanplateletvolume as a diagnostic marker for cardio vascular disease: drawbacks of preanalytical conditions and measuring techniques. Clinical and Applied Thrombosis/Hemostasis. 2012;18(6):561-568.
  • 10.Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Mean platelet volume predicts early death in acute pulmonary embolism. Heart. 2010;96(6):460-465.
  • 11.Fei Y, Zong G-q, Chen J, Liu R-m. Evaluation of thevalue of d-dimer, P-selectin, and platelet count for prediction of portal vein thrombosis after devascularization. Clinical and Applied Thrombosis/Hemostasis. 2016;22(5):471-475.
  • 12.Sansanayudh N, Muntham D, Yamwong S, Sritara P, Akrawichien T, Thakkinstian A. The association between mean platelet volume and cardiovascular risk factors. European Journal of Internal Medicine. 2016;30:37-42.
  • 13.Díaz JM, Boietti BR, Vazquez FJ, et al. Mean platelet volume as a prognostic factor for venous thromboembolic disease. Revistamedica de Chile. 2019;147(2):145-152.
  • 14. Chung T, Connor D, Joseph J, et al. Platelet activation in acute pulmonary embolism. Journal of Thrombosis and Haemostasis. 2007;5(5):918-924.
  • 15. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thrombo embolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of internal medicine. 2002;162(10):1182-1189.
  • 16. Santosa F, Moysidis T, Moerchel C, Kröger K, Bufe A. Pulmonary embolism in young people. Hämostaseologie. 2014;34(01):88-92.
  • 17. Van Es N, Kraaijpoel N, Klok FA, et al. The original and simplified Wells rules and age‐adjusted D‐dimer testing out pulmonary embolism: an individual patient data meta‐analysis. Journal of Thrombosis and Haemostasis. 2017;15(4):678-684.
  • 18. Hakemi EU, Alyousef T, Dang G, Hakmei J, Doukky R. The prognosticvalue of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015;147(3):685-694.
  • 19. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical out comes in the International Cooperative Pulmonary EmbolismRegistry (ICOPER). The Lancet. 1999;353(9162):1386-1389.
  • 20.Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Mean platelet volum predicts early death in acute pulmonary embolism. Heart. 2010;96(6):460-465.
  • 21. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: TheTask Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). EurHeart J 2008;29:2276e315.
  • 22.Yardan T, Meric M, Kati C, Celenk Y, Atici AG. Mean platelet volume and mean platelet volume/platelet count ratio in risk stratification of pulmonary embolism. Medicina. 2016;52(2):110-115.
  • 23. Şen H, Abakay Ö, Taylan M, Tanrıkulu A, Sezgi C. The importance of mean platelet volume in early mortality of pulmonary embolism. J Clin Exp Invest. 2013;4(3):298- 301.
  • 24. Díaz JM, Boietti BR, Vazquez FJ, et al. Mean platelet volume as a prognostic factor for venous thrombo embolic disease. Revista medica de Chile. 2019;147(2):145-152.
  • 25. Türk Toraks Derneği PulmonerTromboembolizm Tanı ve Tedavi Uzlaşı Raporu 2021. 2021: 22.
  • 26. Ming L, Jiang Z, Ma J, Wang Q, Wu F, Ping J. Platelet-to-lymphocyteratio, neutrophil-to-lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis. Vasa. 2018.
  • 27.Han JS,Park TS,Cho SY,Joh JH,Ahn HJ. Increased mean platelet volume and mean platelet volume/platelet countratio in Korean patients with deep vein thrombosis. Platelets. 2013;24(8):590-593.
There are 27 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Research Articles
Authors

Elif Yılmaz 0000-0003-2909-5077

Makbule Özlem Akbay 0000-0002-2459-8022

Abdurrahman Yılmaz 0000-0001-7663-6388

Dilek Ernam 0000-0001-9008-4508

Project Number yoktur
Publication Date December 21, 2021
Submission Date August 24, 2021
Published in Issue Year 2021

Cite

APA Yılmaz, E., Akbay, M. Ö., Yılmaz, A., Ernam, D. (2021). Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?. Abant Medical Journal, 10(3), 380-387. https://doi.org/10.47493/abantmedj.986721
AMA Yılmaz E, Akbay MÖ, Yılmaz A, Ernam D. Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?. Abant Med J. December 2021;10(3):380-387. doi:10.47493/abantmedj.986721
Chicago Yılmaz, Elif, Makbule Özlem Akbay, Abdurrahman Yılmaz, and Dilek Ernam. “Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?”. Abant Medical Journal 10, no. 3 (December 2021): 380-87. https://doi.org/10.47493/abantmedj.986721.
EndNote Yılmaz E, Akbay MÖ, Yılmaz A, Ernam D (December 1, 2021) Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?. Abant Medical Journal 10 3 380–387.
IEEE E. Yılmaz, M. Ö. Akbay, A. Yılmaz, and D. Ernam, “Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?”, Abant Med J, vol. 10, no. 3, pp. 380–387, 2021, doi: 10.47493/abantmedj.986721.
ISNAD Yılmaz, Elif et al. “Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?”. Abant Medical Journal 10/3 (December 2021), 380-387. https://doi.org/10.47493/abantmedj.986721.
JAMA Yılmaz E, Akbay MÖ, Yılmaz A, Ernam D. Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?. Abant Med J. 2021;10:380–387.
MLA Yılmaz, Elif et al. “Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?”. Abant Medical Journal, vol. 10, no. 3, 2021, pp. 380-7, doi:10.47493/abantmedj.986721.
Vancouver Yılmaz E, Akbay MÖ, Yılmaz A, Ernam D. Akut Pulmoner Embolide Ortalama Trombosit Hacmi Erken Dönem Mortaliteyi Gösteren Bir Belirteç Midir?. Abant Med J. 2021;10(3):380-7.